Former U.S. Presidents Barack Obama, George W. Bush and Bill Clinton said they were willing to be vaccinated against the novel coronavirus on television in order to ease any public skepticism over the safety of new vaccines.
U.S. Supreme Court justices signaled they are unlikely to strike down the Obamacare healthcare law in a legal challenge brought by Texas and 17 other Republican-governed states and joined by President Donald Trump’s administration.
Drug companies’ political committees have largely donated to Republican presidential campaigns since 1990, but that trend has noticeably reversed come the 2020 election cycle, according to a new report from the Center for Responsive Politics.
Sander Flaum, Principal of Flaum Navigators, believes that it’s absolutely essential that healthcare access is improved in the United States, but he has no confidence that anyone in Washington has the courage or clout to enact the substantial changes that need to be made.
Americans’ anxieties over the spread of the coronavirus are at the highest in more than a month, a Reuters/Ipsos poll showed on Wednesday, as California recorded the state’s largest single-day spike in cases since the pandemic began.
Republican and Democratic U.S. senators called for a government analysis of foreign influence in the U.S. pharmaceutical supply chain, saying the coronavirus pandemic has exposed an over-reliance on China and other countries for the production of essential drugs.
The coronavirus outbreak could reach its peak in the United States this week, a top U.S. health official said as more signs of stabilization emerged, but political leaders said a reopening of the economy may hinge on more widespread testing.
Bristol-Myers Squibb Co. and Celgene Corp. won U.S. antitrust approval for their merger on condition that they sell Celgene’s psoriasis drug Otezla.
Senate Finance Committee Chairman and Republican Chuck Grassley and the panel’s leading Democrat, Senator Ron Wyden, announced a bipartisan proposal to lower the Rx drug prices.
A federal appeals court panel expressed skepticism to Democratic calls to overturn the ruling of a Texas judge who found the landmark U.S. healthcare reform law unconstitutional.
